Duhilag, Trecia Mae T.

HRN: 14-37-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
CEFUROXIME 1.5GM (VIAL)
08/03/2023
08/09/2023
IV
1.5 Gms
Now Then Q 8 Hrs
S/P LTCS
Waiting Final Action 
08/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/03/2023
08/09/2023
IVT
500mg
Now Then Q 8 Hrs
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: